JI101 是一种有口服活性的多靶点激酶抑制剂，能够抑制VEGFR2，PDGFRβ和EphB4，具有抗癌作用。

JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4).

900573-88-8

C22H20BrN5O2

466.339

CGI-1842;JI 101

DMSO:10 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years